ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
Results indicated PMN310 was generally well-tolerated and monthly dosing can provide CSF levels adequate for target ...
The Malta Independent7h
Hope for ALS patients after ‘breakthroughs’ with new treatments ‘in the pipeline’
Ruben J. Cauchi, Professor of Neurogenetics within the Department of Physiology & Biochemistry at the Faculty of Medicine & Surgery Cauchi described ALS (amyotrophic lateral sclerosis) as follows: ...
StockNews.com Begins Coverage on Aeterna Zentaris (NASDAQ:AEZS)
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical ...
BusinessGhana9h
UG, Google, and UCL develop speech recognition technology for Ghanaian languages
The initiative, named T?kyer?ma Pa, aims to enhance communication for individuals with non-standard speech patterns due to conditions such as Cerebral Palsy, Stroke, Down Syndrome, Amyotrophic Lateral ...
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
'We’re here to keep up the fight': Idaho Pizza Company ALS fundraiser for late employee
Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...
Aaron Lazar Receives Grammy Nomination for Debut Album Recorded After Being Diagnosed with ALS
Aaron Lazar received his first-ever Grammy nomination on Friday, Nov. 8 for his debut album, 'Impossible Dream.' It was an ...